PBT swung to a NZ$10.6m loss despite 11.6% revenue growth

Despite that top line, the group swung deeper into loss: PBT moved from -NZ$0.4m to -NZ$10.6m (PBT growth n/m) and NPAT fell to -NZ$10.5m (NPAT growth n/m). Operating profit turned negative at -NZ$0.2m versus +NZ$5.9m.

Segment mix did most of the work in opposite directions. Australian Glass Group revenue grew to NZ$76.8m and its result improved to NZ$6.4m from -NZ$0.3m; New Zealand revenue rose 5% to NZ$186.7m but its segment result deteriorated sharply versus the NZ$7.4m it earned a year ago.

Operating cash flow fell 56.9% to NZ$5.7m, cash on hand halved to NZ$7.3m, and net debt rose to NZ$60.1m (3.2x EBITDA of NZ$18.8m). Total equity fell 11.8% to NZ$75.5m.

AGG's NZ$6.4m result and 32% revenue growth marked a genuine turnaround, but it was more than absorbed by the NZ segment's reversal from a NZ$7.4m profit to a meaningfully negative contribution. This matters because the dominant segment (70.8% of revenue) is the one driving the loss, so the read on the consolidated result depends almost entirely on when NZ pricing and cost recovery actually flows through.

Cash conversion fell hard despite revenue growth. OCF/EBITDA was 30.4% and operating cash inflow dropped NZ$7.5m year on year, while operating working capital expanded by roughly NZ$7.5m. Inventory days at 44.1 sit above the supplied historical range (mean 41.7, range 39.1–43.5) and trade debtors grew 8.9%. The implication: reported EBITDA of NZ$18.8m is not translating into cash, and the working-capital build is consuming the headline revenue uplift.

Leverage is moving the wrong way. Net debt rose from NZ$52.3m to NZ$60.1m while equity fell 11.8%, leaving net debt/EBITDA at 3.2x and the cash balance at NZ$7.3m. Management's own commentary acknowledges that "the debt legacy remains," and with FCF/NPAT at just 3.5%, debt reduction depends on the working-capital release management is signalling for 2023.

There are no forward revenue or earnings targets supplied to test against.

The shape, however, is unfavourable: HY23 carried 80.1% of full-year EBITDA, implying H2 EBITDA of only about NZ$3.7m on H2 revenue of NZ$125.4m. This matters because the second half is the run-rate going into FY24, and the management commentary on NZ gross-margin recovery and working-capital release is a 2023 calendar-year forward claim that the FY23 statutory result does not yet evidence.

That looks like underlying improvement rather than a timing effect.

The remainder of the result is lower quality. The headline tax line is effectively neutral (effective tax rate 0.3% versus a historical mean of 12.0%), so PBT is the cleaner operating read and PBT is where the deterioration sits. EBITDA of NZ$18.8m converted to only NZ$5.7m of operating cash and roughly -NZ$0.4m of FCF pre-lease after NZ$6.1m of capex, with FCF/NPAT at 3.5%. Inventory days above the historical range and a NZ$7.5m working-capital build mean a meaningful share of the apparent earnings is sitting on the balance sheet rather than in cash. PBT margin at -4.0% and NPAT margin at -4.0% both remain within the supplied historical range, so the margin level is not unusual for this company, but the cash-quality and leverage trajectory are what differentiate this period.

This briefing cannot assess management's qualitative claims about FY24 margin recovery or the durability of AGG pricing without forward financial disclosure.